Incidence of AIDS-defining Illness by Cancer Status in an Observational Study among Medicaid Beneficiaries Living with HIV in the United States, 2001 – 2015
Incidence of new ADIs was elevated after cancer diagnosis. PWH undergoing cancer treatment may require careful observation for ADI development and potentially warrant consideration of immune-sparing cancer treatment regimens given prior data suggesting sustained decreases in CD4 cell counts after cancer treatment.
Authors
- Eryka Wentz (ORCID: https://orcid.org/0000-0002-9056-0436)
- Bryan Lau (ORCID: https://orcid.org/0000-0002-2355-612X)
- Karine Yenokyan (ORCID: https://orcid.org/0000-0001-6835-9405)
- Corinne E. Joshu (ORCID: https://orcid.org/0000-0002-5100-172X)
- Xueer Zhang
- Jacqueline E. Rudolph (ORCID: https://orcid.org/0000-0001-7177-1847)
- Keri L. Calkins (ORCID: https://orcid.org/0000-0003-0003-9397)
- Yiyi Zhou (ORCID: https://orcid.org/0009-0000-7553-0928)
- Xiaoqiang Xu (ORCID: https://orcid.org/0000-0003-1319-1646)
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Mathematica Policy Research (US)
Publication Details
- Journal
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1097/qai.0000000000003820
- Citations
- 1
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.05